{"id":"W2947775394","doi":"10.1200/jco.19.00934","title":"Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1185,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Pembrolizumab; Overall survival; Lung cancer; Safety profile; Phases of clinical research; Survival rate; Cancer; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001303204,0.0002287676,0.001318609,0.00005239204,0.00006518605,0.00001643309,0.0002498374,0.0002137691,0.0001462808],"category_scores_gemma":[0.0003299956,0.0001095347,0.0002923182,0.000132795,0.0001184828,0.0001064767,0.00002880304,0.0006702083,0.000003986321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002160834,"about_ca_system_score_gemma":0.001227233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005998812,"about_ca_topic_score_gemma":0.0006740182,"domain_scores_codex":[0.9970221,0.0003070209,0.001606067,0.0003336384,0.0004377814,0.0002933878],"domain_scores_gemma":[0.9940013,0.002860307,0.001861461,0.0003607323,0.0007187934,0.0001973758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5069,0.008801681,0.4618699,0.00001808505,0.001502027,0.00006349218,0.0003464732,0.00005990962,0.0001294848,5.651299e-7,0.002462503,0.01784584],"study_design_scores_gemma":[0.3197525,0.08178364,0.583197,0.0001826613,0.000922045,0.00000507761,0.0003736066,0.0001238783,0.00004051127,0.000002835066,0.0134721,0.0001441624],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949187,0.0002102493,0.00002952657,0.00130581,0.0009149317,0.001851518,0.0001532204,0.000009561762,0.000606453],"genre_scores_gemma":[0.9962134,0.0003029879,0.0005825346,0.001175649,0.0006551133,0.00002475715,0.00004631916,0.00003721593,0.0009619929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1871476,"threshold_uncertainty_score":0.4466696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04314214802703654,"score_gpt":0.41046673368768,"score_spread":0.3673245856606435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}